Dennis A. Ausiello

Biography

 Dr. Dennis Arthur Ausiello, also known as Denny, M.D. is the Jackson Professor of Clinical Medicine at Harvard Medical School. Dr. Ausiello is a Strategic Advisor of Proventys, Inc. Dr. Ausiello serves as an Advisor of InCube Labs, LLC. Dr. Ausiello has been Advisor at PureTech Health PLC since November 30, 2015. He served as the Physician-in-Chief of the Department of Medicine and Chief of Medical Services at The General Hospital Corporation (Massachusetts General Hospital (MGH)) since 1996. Dr. Ausiello served as the Chief Scientific Officer at Partners HealthCare System, Inc. He served as the Chief of the MGH Renal Unit from 1983 to 1996 and oversaw its development into one of the most sought after research and training programs in the world. Dr. Ausiello's experience includes President of the Association of American Physicians in 2006. He has been a Director and Member of the Scientific Advisory Board at Alnylam Pharmaceuticals, Inc. since April 2012. Dr. Ausiello serves as a Director at Broad Institute and Taris Biomedical, Inc. He serves as a Director of LiRIS Biomedical, Inc. and EnBiotix, Inc. He has been a Director of Tarveda Therapeutics, Inc. (alternate name: Blend Therapeutics, Inc.) since January 2015 and Seres Therapeutics, Inc. since May 2015. Dr. Ausiello serves as a Member of Board of Advisors at InCube Ventures, LLC. He serves as a Member of the Scientific Advisory Board at Verily Life Sciences LLC and Boston BioCom LLC. He serves as a director of the Center for Assessment Technology and Continuous Health (CATCH). Dr. Ausiello serves as a Member of the Advisory Board at Polaris Partners. He has been an Independent Director of Pfizer Inc., since December 1, 2006 and serves as its Lead Independent Director. He served as Member of Scientific Advisory Board at BIND Therapeutics, Inc. (alternate name, BIND Biosciences, Inc.). He served as a Director of Microchips Biotech, Inc. (MicroCHIPS, Inc.). He served as Member of the Scientific Advisory Board at Pulmatrix, Inc., Tarveda Therapeutics, Inc. and Promedior, Inc. Dr. Ausiello was a Fellow of the American Academy of Arts and Sciences. He serves as the Co-editor of Cecil's Textbook of Medicine (Elsevier). He has made a substantial contribution to knowledge of epithelial biology in the areas of membrane protein trafficking, ion channel regulation and signal transduction and has published over 100 papers, chapters and textbooks. A nationally recognized leader in academic medicine, Dr. Ausiello was elected to the Institute of Medicine of the National Academy of Sciences in 1999 and the American Academy of Arts and Sciences in 2003. He is a 1967 cum laude graduate of Harvard College, where he received a Bachelor's degree in Biochemical Sciences and of the University of Pennsylvania School of Medicine where he received his Medical Degree in 1971.

Research Interest

 Epithelial biology in the areas of membrane protein trafficking, ion channel regulation and signal transduction